and mitochondrial calcium content that accompany ischemic and t,oxic acute renal failure have been suggested to mediate renal tubular cell injury and dysfunction, but the mechanism(s) are unknown. We studied the effects of in vivo vitamin D-induced chronic hypercalcemia on rat renal cortical brush-border and basolateral membranes and mitochondria. In the brush-border membrane, hypercalcemia caused significant decreases in alkaline phosphatase-specific activity, tot,al phospholipid molar content, and phosphatidylserine percent molar composition and increases in the cholesterol-tototal phospholipid molar ratio and phosphatidylinositol percent> molar composition.
of vitamin D-induced chronic hypercalcemia on rat renal cortical plasma membranes and mitochrondria.
Am. J. Physiol. 252 (Renal Fluid Electrolyte Physiol. 21): F267-F275, 1987.-Increases in intracellular and mitochondrial calcium content that accompany ischemic and t,oxic acute renal failure have been suggested to mediate renal tubular cell injury and dysfunction, but the mechanism(s) are unknown. We studied the effects of in vivo vitamin D-induced chronic hypercalcemia on rat renal cortical brush-border and basolateral membranes and mitochondria. In the brush-border membrane, hypercalcemia caused significant decreases in alkaline phosphatase-specific activity, tot,al phospholipid molar content, and phosphatidylserine percent molar composition and increases in the cholesterol-tototal phospholipid molar ratio and phosphatidylinositol percent> molar composition.
In the basolateral membrane, hypercalcemia caused significant decreases in Na'-K'-ATPase-specific activity and total phospholipid molar content and increases in the cholesterol-to-total phospholipid molar ratio and phosphat.idylinositol 4,5-bisphosphate percent molar composition" In the mitochondria, hypercalcemia caused a mild increase in the mitochondrial calcium content, but no alterations in succinic dehydrogenase-specific activity, succinate-, ADP-, or uncoupler-induced respiration. Thus hypercalcemia caused alterations in brush-border and basolateral membrane enzyme activity and lipid composition, but no functional changes were detected in mitochondria.
These hypercalcemia-induced plasma membrane biochemical alterations may be markers of early cell injury and suggest a role for calcium in causing or predisposing to renal t,ubular cell injury.
calcium; brush-border and basolateral membrane; enzyme activity; lipid composition; mitochondrial respiration THE INCREASE in intracellular and mitochondrial calcium content. that occurs in ischemia and toxin-induced acute renal failure (3, 7, 24, 35, 36) has been proposed to play an important role in the pathogenesis of renal tubular cell injury and dysfunction (7). These models of acute renal failure are associated with severe cell damage and necrosis. The increase in intracellular and mitochondrial calcium, and the associated plasma membrane and mitochondrial biochemical alterations and functional impairments (13, 27, 36) could therefore be a consequence, rather than the cause, of tubular cell injury and dysfunction. On t<he basis of these studies a primary role for calcium in causing or predisposing to renal tubular cell injury has been difficult to determine. In recent studies, however, acute or chronic hypercalcemia in the rat has been shown to enhance ischemia and toxin-induced acute renal failure (8, 16, 28, 33) . These preliminary studies therefore suggest a potentially important role for calcium in predisposing to renal tubular cell injury. The present study was designed to examine the effects of chronic hypercalcemia in the rat on renal cortical brush-border, basolateral, and mitochondrial membrane. Since the model of vitamin D-induced chronic hypercalcemia is associated with only mild impairments in renal blood flow, glomerular filtration rate (17), and tubular function (18), it allows t.he study of the effects of calcium on the subcellular organelles in the absence of severe cell injury and prior to the manifestations of acute renal failure. The results of the present study demonstrate that hypercalcemia causes significant impairments in renal cortical brush-border membrane and basolateral membrane enzyme activity and lipid composition, although this degree of hypercalcemia does not cause significant impairments in mitochondrial enzyme activity or respiration.
METHODS
General. All studies were performed on male Fischer 344 rats (Charles River, Wilmington, MA) weighing between 225 and 275 g. Rats were fed a commercially obtained control diet (ICN Nutritional Biochemicals, Cleveland, OH). Hypercalcemia was induced by supplementation of the control diet with dihydrotachysterol (DHT, Roxane Laboratories, Columbus, OH) (4.25 mg DHT/kg of diet). In addition, to determine the effects of DHT in the absence of changes in serum calcium, a third group of rats was fed a diet supplemented with a nonhypercalcemic dose of DHT (0.425 mg DHT/kg of diet). In pilot studies we determined that this was the maximal dose of DHT that caused hypercalciura, but did not cause an increase in serum total or ionized calcium concentration. All rats on the control and DHT-supplemented diets were weight and age-matched at the onset of each experiment, and were pair fed throughout the experimen-tal period. All studies were performed after 8 days on the control or DHT diets.
Determination of serum calcium concentration, cortical homogenate, brush-border membrane, basolateral membrane, and mitochondrial calcium content. Serum total calcium concentration was measured by an atomic absorption spectrophotometer (Perkin Elmer, Norwalk, CT), and serum ionized calcium concentration was measured by an ionized calcium analyzer (Nova 2, Nova Biochemical, Newton, MA). For measurement of tissue calcium content, aliquots of cortical homogenate, brushborder membrane, basolateral membrane, and mitochondria were digested with concentrated nitric acid, and the contents were diluted with distilled and deionized water in acid-washed plastic tubes prior to measurement by atomic absorption spectrophotometer. Calcium content is expressed as nanomoles Ca per milligram protein.
Isolation of brush-border and basolateral membranes and mitochondria. Brush-border and basolateral membranes from the renal cortical tissue of hypercalcemic and normocalcemic control rats were simultaneously isolated by a differential centrifugation, magnesium precipitation, and discontinuous sucrose gradient method as previously described by Molitoris and Simon (26). Rats were lightly anesthetized with ether, the kidneys were removed through a midabdominal incision and placed in an ice-chilled isolation buffer containing 300 mM mannitol, 5 mM ethyleneglycol-bis (P-aminoethylether)-N,-N&N'-tetraacetic acid (EGTA), 0.1 mM phenylmethylsulfonyl fluoride (PMSF), and 18 mM tris-(hydroxymethyl)aminomethane (Tris), pH 7.4. EGTA, a chelator of calcium, and PMSF, a protease inhibitor, were added to the isolation buffer to minimize potential effects of calcium, phospholipases, and proteases during the isolation procedure on the resultant brush-border and basolateral membrane enzyme activity and lipid composition. Thin cortical sections were obtained and homogenized using a polytron (Brinkman, Westbury, NY). The brush-border and basolateral membranes were then isolated from the cortical homogenate as previously described (26).
Mitochondria from the renal cortical tissue of hypercalcemic and normocalcemic control rats were isolated by a differential centrifugation method as previously described by Wilson et al. (36) . Rats were lightly anesthetized with ether, the kidneys were removed through a midabdominal incision and placed in an ice-chilled isolation buffer containing 210 mM mannitol, 70 mM sucrose, 200 ,uM ruthenium, 0.5% fat-free bovine serum albumin (BSA), and 2 mM K-N-Z-hydroxyethyipiperazine ethanesulfonic acid (HEPES), pH 7.4. Ruthenium red, a specific inhibitor of mitochondrial calcium influx via the electrophoretic mitochondrial calcium uniporter, was added to the isolation buffer to exclude any role for mitochondrial calcium influx during the isolation procedure on the resultant mitochondrial calcium content and mitochondrial respiration. EGTA, a chelator of calcium, was not added to the isolation buffer, to avoid mitochondrial calcium efflux during the isolation procedure. Thin cortical sections were obtained and homogenized using a PoLLer-Elvehjem tissue homogenizer. The mitochondria were then isolated from the cortical homogenate as previously described (36).
Determination of enzyme activity. Enzyme activity determinations were made on homogenates and membrane fractions frozen at -20°C for 12 h. Enzyme activity assays were performed under conditions of substrate concentration and reaction time so that the rate of each reaction was linearly related to the amount of sample protein added. Specific activities of Na+-K+-ATPase (basolateral membrane bound), alkaline phosphatase and leucine aminopeptidase (brush-border membrane bound), succinic dehydrogenase (mitochondrial membrane bound), NADPH cytochrome c reductase (endoplasmic reticular membrane bound), and N-acetyl-P-Dglucosaminidase (lysosomal membrane bound) were measured in samples of homogenates and basolateral, brush-border, and mitochondrial membrane fractions, as previously described (25-27), using a Beckman spectrophotometer (Fullerton, CA) equipped with a kinetic and temperature control unit.
Na+-K+-ATPase activity was measured using an assay system coupled to pyruvate kinase, phosphoenolpyruvate, and lactate dehydrogenase at 340 nm and 37°C. Alkaline phosphatase activity was measured by a kinetic assay, monitoring the production ofp-nitrophenolate and phosphate from p-nitrophenyl phosphate at 405 nm and 37°C. Leucine aminopeptidase activity was measured by a kinetic assay, monitoring the conversion of L-leucine4nitroanilid at 380 nm and 37OC. Succinic dehydrogenase activity was measured by a kinetic assay, monitoring the production of reduced, 2,6-dichlorophenolindophenol at 600 nm and 37°C. NADPH cytochrome c reductase activity was measured by a kinetic assay, monitoring the increase in absorbance produced by the reduction of cytochrome c at 550 nm and 37°C. bhx?tyl-P-D-ghCOSaminidase activity was determined spectrophotometritally at 405 nm and 37°C by measuring the conversion of p-nitrophenyl-N-acetyl-p-D-glucose aminidine to pnitrophenol. Enzyme activities are expressed as micromoles per hour per milligram protein. Protein was determined by the method of Lowry et al. (21) using crystalline BSA as standard.
Enrichment (specific activity in membrane fraction/ specific activity in homogenate) and recovery (total activity in membrane fraction/total activity in homogenate) of each membrane fraction was determined using the above enzymes as markers of specific subcellular organelles.
Lipid extraction and determination of membrane lipid composition. Total lipids were extracted by the method of Bligh and Dyer (4). One milligram of homogenate, brush-border and basolateral membrane protein was used for the extraction. Coprostanol (Supelco, Bellefonte, PA) was included as an internal standard for cholesterol determination. The original sample was extracted twice and the combined extract evaporated to residue under nitrogen. The residue was resuspended in chloroform and divided into aliquots for cholesterol, total, and individual phospholipid determinations.
The cholesterol sample was evaporated to a residue and resuspended in hexane and injected into a 30% SP 
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2250 glass-packed column (Supelco) in a gas liquid chromatograph (Perkin-Elmer model 3920B, Norwalk, CT), run isothermally at 285°C with coprostanol serving as internal standard. Peak height and area ratios were used for quantitation and cholesterol expressed in nanomoles per milligram protein.
The phospholipid sample was dried to residue and resuspended in chloroform. Phospholipid content in the total lipid extract was determined by measuring the phosphorus content by the method of Ames and Dubin (2) . Individual phospholipid polar head group species were isolated by two-dimensional thin-layer chromatography (TLC) (10). The phospholipid sample was spotted onto Kieselgel Silica Gel 60 precoated TLC plates (Merck, Darmstadt, FRG). The plates were developed in two dimensions. The first dimension solvent system consisted of chloroform:methanol:acetic acid (6525: 10, vol/ vol) and the second, chloroform:methanol:88% formic acid (65:25:10, vol/vol). This system results in an excellent separation of sphingomyelin, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol, as well as lysophosphatidylcholine and lysophosphatidylethanolamine.
After development, chromatograms were allowed to dry and then were exposed to iodine crystals. Individual phospholipids were identified by comparison with cochromatography of authentic standards (Supelco). Areas of silica gel containing phospholipids were scraped into acid-washed test tubes. The phospholipids were reextracted from the gel by the Bligh and Dyer method, the silica gel was removed by centrifugation, and the phospholipids were separated into the chloroform phase. The sample was dried to a residue, and the phosphorus content was determined by the Ames and Dubin method. Samples were corrected for background by using an area of the TLC plate known to be free of phospholipids. Phospholipid content is expressed as nanomoles per milligram protein. The percent recovery of phospholipids from the TLC plate and reextraction from the gel was determined by dividing the sum amount of individual phospholipids by the total phospholipid applied to the TLC plate.
For the analysis of anionic phospholipids including phosphotidylinositol, phosphatidylinositol 4-phosphate, phosphotidylinositol4,5-bisphosphate, and phosphatidic acid, 2 mg of brush-border or basolateral membrane protein was extracted by the method of Grove et al. (12) in 6 ml chloroform:methanol (l:l, vol/vol) containing 10 mM tetrabutylammonium sulfate (TBAS). The extracts were evaporated under nitrogen, chloroform was added and washed once with 0.1 N HCl and three times with theoretical upper phase made with ch1oroform:O.l N HCl (l:l, vol/vol). In preliminary studies we found that extracting the anionic phospholipids by the amphiphilic ion-pairing reagent TBAS was far more efficient than extracting with chloroform:methanol solvent systems that included either KC1 or HCl. For the separation of phosphatidylinositol, phosphatidylinositol 4-phosphate, and phosphatidylinositol4,5-bisphosphate, lipid samples were applied to silica gel HL prechanneled TLC plates with preabsorbent phase (Analtech, Newark, DE) and run in one dimension in a solvent svstem of chloroform:methanol:ZO% aqueous methylamine (60:36:10, vol/ vol) (31). For the separation of phosphatidic acid, lipid samples were applied to the silica gel HL TLC plates and were run in one dimension in a solvent system of chloroform:pyridine:formic acid (50:30:5, vol/vol) (31). The phospholipid spots were visualized, identified, extracted from the gel, and quantified by the Ames and Dubin phosphate assay as described above.
Determination of mitochondrial respiration. Mitochondrial respiration was measured polarographically in a closed reaction vessel fitted with a Clark 0, electrode (Yellow Springs Instrument, Yellow Springs, OH) at 25°C in a volume of 1.7 ml (36). The incubation medium was composed of 120 mM KCl, 2 mM KHP04, 4 PM rotenone, 1 mM EGTA, and 5 mM Tris HCl, pH 7.1. Mitochondria (2 mg protein) were energized with the addition of 5 mM K-succinate. After a short equilibration period, state 3 respiration (S3) was induced by the addition of 300 nmol of adenosine diphosphate (ADP). After all the added ADP was phosphorylated to ATP, state 4 respiration (S4) was measured. The ratio of OZ consumption in the presence of ADP to that in its absence (S3/S4) was termed the acceptor control ratio (ACR). In addition, maximal rate of 0, consumption was measured with the addition of 0.2 nmol of carbonyl cyanide p-trifluoromethoxyphenyl hydrasone (FCCP), an uncoupler of oxidative phosphorylation. Mitochondrial respiration is expressed as natoms 0, per minute per milligram protein.
Statistical analyses. All values reported represent the mean t SE. The unpaired t test (two-tailed) was used to evaluate the significance of differences between the normocalcemic and hypercalcemic rats. Significance was accepted at P < 0.05.
RESULTS
Effects of vitamin D diets on serum calcium concentration, cortical homogenate, brush-border membrane, basolateral membrane, and mitochondrial calcium content. Dietary vitamin D supplementation (4.25 mg DHT/kg diet) significantly increased serum total calcium concentration to 12.8 t 0.2 vs. 10.0 t 0.1 mg/dl in normocalcemic control rats, P < 0.01, and serum ionized calcium concentration to 6.7 t 0.2 vs. 5.4 t 0.1 mg/dl in normocalcemic control rats, P < 0.01. As per design of the study, dietary vitamin D supplementation with lower DHT doses (0.425 mg DHT/kg diet) did not cause significant changes in serum total (9.7 t 0.1 mg/dl) or ionized (5.3 t 0.1 mg/dlj calcium concentration.
Dietary vitamin D supplementation also significantly increased cortical homogenate calcium content to 28.5 t 4.1 vs. 15.0 t 2.3 nmol Ca/mg cortical protein in normocalcemic control rats, P < 0.01. There was also a minor but significant increase in the mitochondrial calcium content of the hypercalcemic rats, 14.6 t 0.5 vs. 11.4 t 0.2 nmol Ca/mg mitochondrial protein in normocalcemic control rats, P c 0.01. There was no measurable calcium in the brush-border or basolateral membranes from the hypercalcemic or normocalcemic rats. This is most likely due to the isolation of the brushborder and basolateral membranes in a buffer containing Effects of hypercalcemia on brush-border and basolatera1 membrane, and mitochondrial isolation. Brush-border membranes isolated from normocalcemic and hypercalcemic rats had similar enrichment and recovery for alkaline phosphatase and leucine aminopeptidase activit.ies (Table 1) . Contamination of the brush-border membrane with the other subcellular organelles was minimal and similar, except for a slightly higher contamination with the basolateral membrane in the hypercalcemic rats (Table 1) .
Basolateral membranes isolated from normocalcemic and hypercalcemic rats were similarly enriched for Na+-K+-ATPase activity (Table 1 ). Recovery of Na+-K+-ATPase activity and contamination of the basolateral membrane with the other subcellular organelles were similar in normocalcemic and hypercalcemic rats ( Table  1) .
Mitochondria isolated from normocalcemic and hypercalcemic rats had similar enrichment and recovery for succinic dehydrogenase activity ( Table 2 ). Contamination of the mitochondria with the other subcellular organelles was similar, except for a slightly higher contamination with the basolateral membrane in the hypercalcemic rats ( Table 2) .
Effects of hypercalcemia on cortical homogenate, brushborder, basolateral, and mitochondrial membrane enzyme activity.
In the cortical homogenate, hypercalcemia caused a 29% decrease in the specific activity of alkaline phosphatase (P < O.Ol), a 22% decrease in the specific activity of Na+-K+-ATPase (P < O.Ol), and a 20% decrease in the specific activity of N-acetyl-P-D-glucoseminidase (Table 3) . Hypercalcemia did not cause significant decreases in the specific activities of leucine aminopeptidase, succinic dehydrogenase, or NADPH cytochrome c reductase (Table 3 ).
In the brush-border membrane, hypercalcemia caused a 34% decrease in the specific activity of alkaline phosphatase (P < 0.01) (Fig. 1) ; there was no significant decrease in the specific activity of leucine aminopeptidase.
In the basolateral membrane, hypercalcemia caused a 26% decrease in the specific activity of Na+-K+-ATPase (P c 0.01) (Fig. 1 ).
In the mitochondria, hypercalcemia did not cause a significant decrease in the specific activity of succinic dehydrogenase (P = NS) ( Table 7) .
Nonhypercalcemic doses of vitamin D did not cause any significant alterations in the alkaline phosphatase specifi.c activity in the cortical homogenate or brushborder membrane, and Na+-K+-ATPase specific activity in the cortical homogenate or basolateral membrane. Therefore, the effects of vitamin D-induced hypercalcemia on alkaline phosphatase and Na+-K+-ATPase specific activities are apparently caused by the hypercalcemia rather than nonhypercalcemic effects of vitamin D .
Effects of hypercalcemia on cortical homogenate, bru,shborder and basolateral membrane lipid composition. In the cortical homogenate, hypercalcemia caused no significant change in the cholesterol molar content, but a 16% decrease in the total phospholipid molar content (P < O.Ol), resulting in a 17% increase in the cholesterolto-total phospholipid molar ratio (P < 0.01) (Table 4 ).
In the brush-border membrane, hypercalcemia caused no significant change in the cholesterol molar content, but a 10% decrease in the total phospholipid molar content (P < 0.05) (Table 5) , resulting in a 15% increase in the cholesterol-to-total phospholipid molar ratio (P < 0.05) (Fig. 2) . Hypercalcemia also caused significant decreases in the molar content of phosphatidylcholine and phosphatidylserine, but when the individual phospholipid content was expressed as the percent molar composition of the total phospholipid content, only the change in the percent composition of phosphatidylserine achieved significance (Table 5 ). In addition, hypercalcemia caused a significant increase in the molar content and percent molar composition of phosphatidylinositol (P < 0.05), but no changes in the molar content of the other anionic phospholipids (Table 6 ). The TLC recovery for the phospholipids did not significantly differ between the hypercalcemic (78.7 t 2.4%) and normocalcemic (77.6 t 4.2%) rats.
In the basolateral membrane, hypercalcemia caused no significant change in the cholesterol molar content, but a 12% decrease in the total phospholipid molar content (P < 0.05) (Table 5) , resulting in a 16% increase in the cholesterol-to-total phospholipid molar ratio (P < 0.05) (Fig. 2) . Hypercalcemia also caused significant decreases in the molar content of sphingomyelin, phosphatidylcholine, and phosphatidylethanolamine, but when the individual phospholipid content was expressed as the percent molar composition of the total phospholipid content, these changes did not achieve significance (Table   TABLE   1 . Enrichment and contamination of brush-border and basolateral membranes isolated from normocalcemic and hypercalcemic rats ______ ______ -----___ Results are expressed as means t SE; n = 6 in each group. * P < 0.01. 5). In addition, hypercalcemia caused a significant increase in the molar content and percent molar composition of phosphatidylinositol4,5bisphosphate (P < 0.05), but there were no changes in the molar content of the other anionic phospholipids (Table 6 ). The TLC recovery for the phospholipids did not significantly differ between the hypercalcemic (65.6 t 2.4%) and normocalcemic (63.3 t 1.5%) rats.
Nonhyperglycemic doses of vitamin D did not cause any significant alterations in cortical homogenate, brushborder, or basolateral membrane cholesterol content, total phospholipid content, cholesterol-to-total phospholipid molar ratio, or individual phospholipid content. Therefore, the effects of vitamin D-induced hypercalcemia on lipid composition is apparently a consequence of the hypercalcemic rather than nonhypercalcemic effects of vitamin D.
Effects of hypercalcemia on mitochondrial respiration. Hypercalcemia caused a mild but significant increase in the mitochondrial calcium content. The increase in the mitochondrial calcium content however, did not significantly affect mitochondrial membrane enzyme activity, or mitochondrial respiration (Table 7) . Specifically, succinate-induced, ADP-induced, or FCCP-induced respiration, and acceptor control ratio were not significantly altered by hypercalcemia (Table 7) .
DISCUSSION
Intracellular and mitochondrial calcium overload that occurs in ischemic and toxic acute renal failure (3, 7, 24, 34, 36) has been proposed to play a role in renal tubular cell injury and dysfunction (7). The experimental models of ischemic and toxic acute renal failure so far studied usually result in severe cell damage and necrosis. The associated cellular calcium overload and the cellular functional impairments and biochemical alterations (13, 27,36) could be a consequence, rather than the cause, of tubular cell injury. It has been, therefore, difficult on the basis of these studies to assign a primary role for calcium in causing cell injury. Recent preliminary studies, however, have shown that acute and chronic hypercalcemia in the rat enhances ischemic and toxic acute renal failure (8, 16, 28, 33), suggesting an important role for calcium in predisposing to renal cell injury. Hypercalcemia, therefore, seems to be a suitable model to examine the cellular effects of calcium-mediated cell injury.
The present study used a model of vitamin D-induced chronic hypercalcemia in the rat that has previously been shown to be associated with only mild decrements in renal blood flow, glomerular filtration rate (l7), and tubular function (18), and therefore allows the study of the effects of calcium on the renal tubular plasma membrane and mitochondria in the absence of severe cell injury and prior to the manifestations of acute renal failure.
Hypercalcemia resulted in a mild but significant increase in the mitochondrial calcium content. Since, in the present study, the mitochondria were isolated in the presence of Ruthenium red, which would inhibit in vitro mitochondrial calcium influx, but in the absence of EGTA, the increase in mitochondrial calcium content induced respiration. Furthermore, in view of the normal enzyme activity and respiration, a significant alteration in mitochondrial membrane lipid composition, although not measured, seems unlikely. Thus moderate hypercalcemia of 7 days duration does not impair cortical mitochondrial enzyme activity or respiration. In the present model of hypercalcemia, impairments in plasma membrane enzyme activity and lipid composition therefore precede impairments in mitochondrial enzyme activity and respiration.
Hypercalcemia caused a significant decrease in the brush-border membrane-bound enzyme alkaline phosphatase specific activity in both the cortical homogenate and brush-border membrane fractions. Hypercalcemia, tase is attached to the brush-border membrane by a strong interaction with phosphatidylinositol (20). In this could reflect an increase in the intramitochondrial cal-regard, gentamicin, a cationic drug, which avidly binds cium as well as an increase in the mitochondrial memto the brush-border membrane phosphatidylinositol(29) brane binding (3) . Nevertheless, the increase in the micauses a decrease in alkaline phosphatase activity (15) tochondrial calcium content did not impair mitochonin spite of causing an increase in the brush-border phosdrial membrane-bound succinic dehydrogenase activity, phatidylinositol molar content (15). Similarly, calcium an enzyme that participates in the electron transport ion, which also avidly binds to phosphotidylinositol, system, or mitochondrial substrate, ADP, or uncouplercould cause a decrease in alkaline phosphatase activity by its interaction with the brush-border membrane phosphatidylinositol. In addition, alkaline phosphatase is an intrinsic membrane enzyme, and the activity of the enzyme is modulated by changes in the composition or fluidity of the membrane bilayer (6, 9). In this regard, hypercalcemia caused a significant increase in the brushborder membrane cholesterol to total phospholipid molar ratio. An increase in this ratio is associated with a decrease in membrane fluidity (25). These findings are compatible with results obtained using fluorescence polarization techniques that have shown calcium ion to decrease the fluidity of rat hepatocyte and intestinal plasma membranes (9,19,34). Taken together, therefore, hypercalcemia may cause a decrease in alkaline phosphatase activity by a direct effect on the enzyme molecule, by interacting with the brush-border membrane phosphatidylinositol, or by potentially causing a decrease in brush-border membrane fluidity. Leucine aminopeptidase, on the other hand, is an extrinsic membrane enzyme, and as in the present study, calcium-phospholipid interactions or membrane lipid compositional or fluidity alterations would not be expected to result in changes in the activity of this brush-border membranebound enzyme (6). Hypercalcemia also caused a significant decrease in the basolateral membrane-bound Na+-K+-ATPase activity in both the cortical homogenate and basolateral membrane fractions. Since Na+-K+-ATPase activity, an intrinsic membrane enzyme, is closely controlled by its interaction with the membrane polyphosphoinositides (32) calcium-polyphosphoinositide interactions may lead'to a decrease in Na+-K+-ATPase activity. In this regard, gentamicin, which avidly binds to membrane polyphosphoinositides (29), causes a decrease in the basolateral membrane bound Na+-K+-ATPase activity (15) in spite of causing an increase in the polyphosphoinositide molar content (30). In addition, the increase in the cholesterol to total phospholipid molar ratio in the basolateral membrane caused by hypercalcemia could result in decreased basolateral membrane fluidity, which may lead to a decrease in Na+-K+-ATPase activity. Previous studies with the hepatocyte plasma membrane have shown that a decrease in membrane fluidity is indeed associated with a decrease in Na+-K+-ATPase activity (14). Taken together, therefore, hypercalcemia may cause a decrease in Na'-K'-ATPase activity by a direct effect on the enzyme complex, by interacting with the basolatera1 membrane polyphosphoinositides, or by potentially causing a decrease in basolateral membrane fluidity.
Since brush-border and basolateral membranes differ from each other in lipid composition (26), as also confirmed in the present study (Table 5) , and relative lipid turnover rate (26), different effects of hypercalcemia on the lipid composition of these two membranes might be expected. In the present study, however, hypercalcemia caused similar decreases in the total phospholipid molar content and increases in the cholesterol-to-total phospholipid molar ratio in both membrane fractions, as well as in the cortical homogenate.
The decrease in the brush-border and basolateral membrane phospholipid content caused by hypercalcemia could result from either decreased synthesis or increased degradation of the membrane phospholipids. In this regard, calcium has been shown to affect the activities of enzymes that modulate both the synthesis and degradation of membrane phospholipids. Calcium has been shown to stimulate phosphatide cytidyltransferase an .d to inhibi .t phosphatide phosphohydrolase activity (5). This would be expected to result in a decreased phosphatidylethanolamine and phosphatidylcholine biosynthesis, and in an increased phosphatidylinositol and polyphosphoinositide biosynthesis, as is the case in the present study (Tables 5 and 6 ). In addition, calcium has been shown to stimulate the activities of phospholipase A2 (II), which induces hydrolysis of the membrane phospholipids and causes increased arachidonic acid release (11, 19, 34) . In addition to causing a potential decrease in the membrane phospholipid content, the decrease in the phospholipid unsaturated fatty acid content, which would decrease membrane fluidity, and the increase in free fatty acid content, which have membrane detergent properties (23), may have adverse effects on membrane function. In the present study we did not detect lysophospholipids including lysophosphatidylcholine and lysophosphatidylethanolamine, but we cannot rule out the presence of increased free fatty acid accumulation in the cortical homogenate or membranes from hypercalcemic rats, since we did not use a TLC solvent system that would separate and identify these lipid breakdown products. The present model of vitamin D-induced hypercalcemia is associated with a fivefold increase in urinary prostaglandin E2 excretion rate (17, 18), which certainly suggests enhanced arachidonic acid release from membrane phospholipids. In fact, in vitro incubation of rat hepatocyte plasma membranes with calcium is associated with a selective decrease in plasma membrane arachidonic acid content, which also results in a decrease in membrane fluidity (19, 34). Therefore, membrane phospholipid hydrolysis and enhanced fatty acid metabolism may be an important cause of the decrease in the membrane phospholipid content and the impairment in membrane enzyme activity in chronic hypercalcemia.
In the present model of vitamin D-induced hypercalcemia, the effects of calcium on enzyme activity and lipid composition cannot be attributed to calcium-independent effects of vitamin D, since nonhypercalcemic doses In addition, in vivo administration of vitamin D has been shown to increase the phosphatidylcholine and the unsaturated fat(ty acid content of rat intestinal and renal brush-border membranes (11, 22) , and in vitro incubation with vitamin D to lower the transition temperature of alkaline phosphatase and to increase the fluidity of rat intestinal brush-border membranes (9), results contrary to those observed and/or suggested in the present study. In addition, it is highly unlikely that the effects of hypercalcemia on enzyme activity and lipid composition are caused by in vitro effects of membrane-bound calcium, since the brushborder and basolateral membranes were isolated in a buffer containing excess amounts of EGTA (-500 nmol EGTA/mg cortical homogenate protein vs. 20 nmol Ca/ mg cortical homogenate protein). Indeed, the final membrane fractions did not have any measurable calcium. Furt*hermore, the final membrane fractions were resuspended in the same buffer containing 5 mM EGTA prior to enzyme and lipid assays.
The renal cortical brush-border and basolateral membrane enzyme activity and lipid compositional alterations caused by hypercalcemia could result in impairment of critical cellular transport processes, alter intracellular ion homeostasis, and thus predispose to renal tubular cell injury. In fact, in a -preliminary study, renal prostaglandin synthesis inhibition with indomethacin resulted in acute renal failure in hypercalcemic, but not in normocalcemic rats (16). In other preliminary studies, hypercalcemia has been shown to significant)ly enhance ischemia (8), gentamicin (ZS), and Bence Jones proteininduced acute renal failure in the rat (33).
The present studies, therefore, demonstrate that hypercalcemia induces significant alterations in renal cortical brush-border and basolateral membrane enzyme activity and lipid composition.
The plasma membrane functional and compositional changes occur prior to any demonstrable impairment in mitochondrial function. These plasma membrane biochemical changes could be cellular markers of early cell injury and suggest a role for calcium in causing renal tubular dysfunction and predisposing to renal tubular cell injury. 31.
